NCT03070184CompletedPhase 2
Race, Natriuretic Peptides and Physiological Perturbations
Racial Differences in the Natriuretic Peptide Response to Exercise and Beta-blockers
Source: ClinicalTrials.gov · Last updated 12 Mar 2025
Brief summary (registry, in English)
The purpose of the study is to understand the origins of differential response to beta-blockers in African-Americans and may provide insight regarding racial differences in cardiovascular risk.
- Status (registry)
- Completed
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 80 (actual)
- First submitted
- 28 Feb 2017
- Start date
- 30 Apr 2017
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- University of Alabama at Birmingham
- Diseases
- High blood pressure
- NCT number
- NCT03070184
What you commit to
- Study type: Interventional · Phase 2
- Participants enrolled: 80
- From 30 Apr 2017 to the primary completion date, 31 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Current or prior smokers
- Pregnant or use of Hormone Replacement Therapy (HRT) or oral contraceptives (OCP) or steroids
Other illness
- History of cardiovascular disease or use of medications for CVD
- History of hypertension or use of BP lowering medications
- Heart rate less than 60 beats/min
- Diabetes or use of anti-diabetic medications
Lab values
- Renal disease (eGFR \< 60ml/min/1.73m2)
Other
- Blood pressure less than 100/60 mm Hg
- Depression
Who the study is looking for
- 18 to 40 years
- Blood pressure less than 140/90 mm Hg
- Able to perform exercise capacity test
- BMI 18-30 kg/m2
- Willing to adhere to study drug
Age in the registry: 18 years to 40 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Alabama at Birmingham Coordinator of this site? Confirm its status | Birmingham | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.